Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Rang in aandelen #29818
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Aandeelprijs
$7.00
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$19.47M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-35.19%
Land
CA
Handel Devonian Health Group Inc. (DVHGF)

Categorie

Koersgeschiedenis voor Devonian Health Group Inc. (DVHGF)
Hoogste slotkoers: $7.00 op 2026-08-01

Laagste slotkoers: $35.44 op 2022-09-01
Koersgeschiedenis van Devonian Health Group Inc. van 2022 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 73.19%
2025 -46.13%
2024 -38.22%
2023 -14.47%
2022 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$743.14 7.12%
CH
$1.07K -5.58%
KR